Premium
Finite entecavir therapy is a feasible alternative to indefinite therapy
Author(s) -
Jeng WenJuei
Publication year - 2014
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.27215
Subject(s) - medicine , entecavir , cumulative incidence , hepatology , incidence (geometry) , hepatitis b , hepatitis b virus , gastroenterology , cohort , immunology , virus , lamivudine , physics , optics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom